Endurance Training in Patients Undergoing Lung Transplantation

January 27, 2020 updated by: Esther Gimenez Moolhuyzen, University Hospital A Coruña

Endurance Training in Patients Undergoing Lung Transplantation: Differences Between Treadmill and Cycle Ergometry Training

Lung Transplantation is usually the last option for patients with chronic respiratory conditions in the late stages of the disease. Pulmonary rehabilitation and, particularly, endurance training, is a cornerstone in the management of these patients both during the pre-operative as well as the post-operative period as it improves cardiopulmonary fitness, muscle mass, muscle strength, health-related quality of life and potentially, survival. However, very few studies have been published addressing which modality of training, intensity, frequency or duration of training provides the best possible results in these patients. Therefore, the objective of this study was to compare two training modalities (treadmill walking versus cycle-ergometry) on functional capacity, muscle strength and lung function.

Study Overview

Status

Unknown

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

80

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients undergoing lung transplantation at the Thoracic Surgery Unit of the Hospital Clínico Universitario de A Coruña.
  • Adults > 18 years.
  • Ability to attend post-surgery exercise training for a minimum period of one month.
  • Sign informed consent.

Exclusion Criteria:

  • Torpid post-operative recovery with a prolonged stay at the Post-Anaesthesia Care Unit > 12 days.
  • Diagnosed with intensive care unit acquired muscle weakness.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Treadmill Training

Participants in the treadmill training group will perform endurance training during the post-operative period using a treadmill (Salter Housewares, UK) for a minimum of 20 sessions. Intensity of training will be set according to 80% of the mean speed achieved during the 6MWT for a targeted time of 30 minutes. Intensity and duration will be adapted to the participant's physical condition, especially during the first week.

After the endurance training, participants will perform resistance training for 20 - 30 minutes for conditioning of the main muscles in the upper and lower limbs using elastic bands, dumbbells and body-weight exercises. Intensity will progressively increase up to 70% of the maximum isometric strength measured with a hand-held dynamometer. Volume of training will also increase from 1 to 3 sets of 12 repetitions each. When needed patients will also be taught breathing exercises and airway clearance techniques.

Endurance training in the form of treadmill/cycle-ergometry
Active Comparator: Cyclo-ergometry Training
Participants in this group will perfom endurance training during the post-operative period using a cycle ergometer (Monark 828e, Monark AB, Sweeden) for a minimum of 20 sessions. Intensity of training will be set according to the results of a symptom-limited incremental cycle-ergometry test performed on the first day to achieve 80% of the maximal workload obtained for a targeted time of 30 minutes. Intensity and duration will be adapted to the participant's physical condition, especially during the first week. Participants in this group will also perfom resistance training and breathing exercises as in the treadmill training group.
Endurance training in the form of treadmill/cycle-ergometry

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
6 Minute Walk Test
Time Frame: 1 month
Distance covered during the 6 Minute Walk Test performed according to the American Thoracic Guidelines.
1 month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
6 Minute Walk Test
Time Frame: 3 Months
Distance covered with the 6 Minute Walk Test performed according to the American Thoracic Guidelines.
3 Months
Maximal isometric strength
Time Frame: 1 and 3 months
Isometrical maximal strength of the brachial biceps and quadriceps muscle of both dominant and non-dominant limbs. Maximal isometric strength will be assessed using a hand-held dynamometer (Lafayette Instrument, Model 01165) and will be presented in kilograms
1 and 3 months
Sit-to-stand
Time Frame: 1 and 3 months
Number of times the patient can stand up from a chair and sit back in 30 seconds
1 and 3 months
Forced Expiratory Volume 1st second (FEV1)
Time Frame: 1 and 3 months
Changes in Forced Expiratory Volume in the 1st second assessed during a forced spirometry test performed according to the international guidelines.
1 and 3 months
Incremental Symptom-Limited Test
Time Frame: 1 and 3 months
Incremental symptom-limited test performed on a cycle-ergometry with a 5-10W increase per minute up to maximal tolerance. Patient was monitorised during the test for both heart rate and oxygen saturation.
1 and 3 months
Maximal inspiratory and expiratory pressures
Time Frame: 1 and 3 months
Maximal inspiratory and expiratory pressures performed with the respiratory muscles
1 and 3 months
Forced Expiratory Capacity (FVC)
Time Frame: 1 and 3 months
Changes in forced expiratory capacity assessed during a forced spirometry test performed according to the international guidelines.
1 and 3 months
Peak Expiratory Flow (PEF)
Time Frame: 1 and 3 months
Changes in peak expiratory flow assessed during a forced spirometry test performed according to the international guidelines.
1 and 3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2016

Primary Completion (Actual)

May 30, 2019

Study Completion (Anticipated)

May 1, 2020

Study Registration Dates

First Submitted

December 27, 2019

First Submitted That Met QC Criteria

January 27, 2020

First Posted (Actual)

January 28, 2020

Study Record Updates

Last Update Posted (Actual)

January 29, 2020

Last Update Submitted That Met QC Criteria

January 27, 2020

Last Verified

January 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • EGM-TXP-2016

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Lung Transplantation

Clinical Trials on Exercise Therapy

Subscribe